February 1, 2019
Dr. Verstovsek on Benefit of Ruxolitinib in Polycythemia Vera

Benefit of Ruxolitinib Treatment in Polycythemia Vera by Dr. Verstovsek

Dr. Verstovsek on Benefit of Ruxolitinib Treatment in PV Srdan Verstovsek, MD, PhD, director of the Hanns A. Pielenz Clinical Research Center for Myeloproliferative Neoplasms at […]
December 21, 2018
PAN Foundation provides patient assistance program for medications for MPN patients

MPN Cancer Connection partners with PAN Foundation on Medication Assistance Programs for MPN Patients

by David Wallace MPN Cancer Connection is very pleased to announce a new partnership with the PAN Foundation.  Myeloproliferative Neoplasm (MPN) patients may be eligible for […]
August 7, 2018

Risk of Myeloid Blood Cancers are increased in relatives of patients

  The largest ever study of its type is the first to definitively show an increased risk of blood cancers in relatives of patients. A team […]
July 16, 2018
MPN patient advocacy, Nathalie Cook

MPN Patient Advocacy Works

Brilliant work by Nathalie Cook lobbying the Australian Government for access to affordable drugs for Cancer Patients Inspiring, tenacious and rewarding work that will benefit the […]
April 9, 2018
MPN research

ASH Partners with UNC, a ClinGen grantee to Curate Genomic data for Blood Research

Publisher’s Note: My source at the American Society of Hematology (ASH) informed me that “initially MPNs aren’t going to be a primary focus, however, we expect […]
March 9, 2018
MPN cells

Ruxolitinib Metformin combo: A Possible Alternative Treatment for Myeloproliferative Neoplasm Patients

Metformin demonstrates antileukemic activity and may have clinical implications for the treatment of myeloproliferative neoplasms (MPN) in combination with ruxolitinib, according to a study published in Cell Death & […]
Do NOT follow this link or you will be banned from the site!
Malcare WordPress Security